121 related articles for article (PubMed ID: 38902691)
1. Effects of edaravone dexborneol on functional outcome and inflammatory response in patients with acute ischemic stroke.
Chen W; Zhang H; Li Z; Deng Q; Wang M; Chen Y; Zhang Y
BMC Neurol; 2024 Jun; 24(1):209. PubMed ID: 38902691
[TBL] [Abstract][Full Text] [Related]
2. Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
Xu J; Wang A; Meng X; Yalkun G; Xu A; Gao Z; Chen H; Ji Y; Xu J; Geng D; Zhu R; Liu B; Dong A; Mu H; Lu Z; Li S; Zheng H; Chen X; Wang Y; Zhao X; Wang Y;
Stroke; 2021 Mar; 52(3):772-780. PubMed ID: 33588596
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial.
Xu J; Wang Y; Wang A; Gao Z; Gao X; Chen H; Zhou J; Zhao X; Wang Y
Stroke Vasc Neurol; 2019 Sep; 4(3):109-114. PubMed ID: 31709115
[TBL] [Abstract][Full Text] [Related]
4. Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial.
Fu Y; Wang A; Tang R; Li S; Tian X; Xia X; Ren J; Yang S; Chen R; Zhu S; Feng X; Yao J; Wei Y; Dong X; Ling Y; Yi F; Deng Q; Guo C; Sui Y; Han S; Wen G; Li C; Dong A; Sun X; Wang Z; Shi X; Liu B; Fan D
JAMA Neurol; 2024 Feb; 81(4):319-26. PubMed ID: 38372981
[TBL] [Abstract][Full Text] [Related]
5. Edaravone dexborneol regulates γ-aminobutyric acid transaminase in rats with acute intracerebral hemorrhage.
Yang R; Li J; Zhao L; Zhang M; Qin Y; Tong X; Wang S; Yang F; Jiang G
J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107738. PubMed ID: 38701940
[TBL] [Abstract][Full Text] [Related]
6. Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke.
Li K; Zhang Q; Lu X; Yao S
J Healthc Eng; 2022; 2022():1509407. PubMed ID: 35463675
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective.
Li J; Cao W; Zhao F; Jin P
BMC Public Health; 2024 Feb; 24(1):436. PubMed ID: 38347500
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Factors as Potential Markers of Early Neurological Deterioration in Acute Ischemic Stroke Patients Receiving Endovascular Therapy - The AISRNA Study.
Deng QW; Huang S; Li S; Zhai Q; Zhang Q; Wang ZJ; Chen WX; Sun H; Lu M; Zhou J
J Inflamm Res; 2021; 14():4399-4407. PubMed ID: 34511974
[TBL] [Abstract][Full Text] [Related]
9. Favorable neuroprotective effect of intra-arterial application of edaravone dexborneol in ischemic stroke rats.
Xi Y; Ma J; Lu S
J Stroke Cerebrovasc Dis; 2023 Nov; 32(11):107356. PubMed ID: 37740991
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats.
Zhang H; Wang L; Zhu B; Yang Y; Cai C; Wang X; Deng L; He B; Cui Y; Zhou W
Eur J Pharmacol; 2023 Jul; 951():175801. PubMed ID: 37207969
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study.
Shi F; He Z; Wang L; Su H; Han S
Front Pharmacol; 2022; 13():938239. PubMed ID: 36330098
[No Abstract] [Full Text] [Related]
12. Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial.
Wang C; Gu HQ; Dong Q; Xu A; Wang N; Yang Y; Wang F; Wang Y
Stroke Vasc Neurol; 2024 Mar; ():. PubMed ID: 38471696
[TBL] [Abstract][Full Text] [Related]
13. Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke.
Huang Y; Zhang X; Zhang C; Xu W; Li W; Feng Z; Zhang X; Zhao K
Mediators Inflamm; 2022; 2022():3855698. PubMed ID: 36032782
[TBL] [Abstract][Full Text] [Related]
14. Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO-1 signaling pathway in mice.
Xu L; Gao Y; Hu M; Dong Y; Xu J; Zhang J; Lv P
Fundam Clin Pharmacol; 2022 Oct; 36(5):790-800. PubMed ID: 35470467
[TBL] [Abstract][Full Text] [Related]
15. Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke.
Hu R; Liang J; Ding L; Zhang W; Liu X; Song B; Xu Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109315. PubMed ID: 36279668
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of edaravone dexborneol versus human urinary kallidinogenase for acute ischemic stroke in China.
Chen P; Luo M; Chen Y; Zhang Y; Wang C; Li H
Health Econ Rev; 2024 Jan; 14(1):7. PubMed ID: 38285185
[TBL] [Abstract][Full Text] [Related]
17. Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage.
Chen Q; Cai Y; Zhu X; Wang J; Gao F; Yang M; Mao L; Zhang Z; Sun B
Front Pharmacol; 2022; 13():848529. PubMed ID: 35529450
[TBL] [Abstract][Full Text] [Related]
18. Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration.
Wang D; Wang Y; Shi J; Jiang W; Huang W; Chen K; Wang X; Zhang G; Li Y; Cao C; Lee KY; Lin L
Int Immunopharmacol; 2024 Mar; 130():111700. PubMed ID: 38382262
[TBL] [Abstract][Full Text] [Related]
19. Associations between Uric Acid Level and 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with/without Edaravone.
Naganuma M; Inatomi Y; Nakajima M; Yonehara T; Ando Y
Cerebrovasc Dis; 2018; 45(3-4):115-123. PubMed ID: 29558754
[TBL] [Abstract][Full Text] [Related]
20. Effects of edaravone dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke.
Hu X; Qian Z; Chen J; Chen M; Zhong W; Shen C; Hu Z; Li R
Transl Neurosci; 2023 Jan; 14(1):20220312. PubMed ID: 37854582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
